Skip to main content

Early-phase Safety and PK Study of a Vaginal Gel

2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
1
YASO GELPhase 11 trial
Active Trials
NCT07281404Not Yet Recruiting72Est. Feb 2028
Yaso Therapeutics
1 program
1
YASO GELPhase 1

Trial Timeline

Clinical trial activity over time

2026
2027
2028
Human BioSciencesYASO GEL

Clinical Trials (1)

Total enrollment: 72 patients across 1 trials

FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL

Start: Apr 2026Est. completion: Feb 202872 patients
Phase 1Not Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.